BioSpace News Archive

Drug Development

Investigator-initiated Phase II Clinical Study of Remetinostat Started in Patients With Basal Cell Carcinoma

edivir AB announced that the first patient has been enrolled and is being dosed with remetinostat gel 1% in an investigator-initiated phase II clinical study in patients with basal cell carcinoma (BCC).

August 2, 2018
·
2 min read
Drug Development

First Patient Enrolled in Mallinckrodt’s Phase 2 Duchenne Muscular Dystrophy Trial

Trial to Assess Efficacy and Safety of Investigational Drug MNK-1411 in Patients with DMD

August 2, 2018
·
5 min read
Business

Aevi Genomic Medicine Reports Second Quarter 2018 Financial Results and Provides Business Update

Announced today financial and operational results for the three months ended June 30, 2018 and provided an overview of the Company’s recent corporate progress.

August 2, 2018
·
14 min read
Business

Nuvo Pharmaceuticals Announces 2018 Second Quarter Results

Reports $1.9 million of Adjusted EBITDA on $5.9 million of Revenue

August 2, 2018
·
14 min read
Drug Development

Regenera Pharma Enrolls First Patient in US Phase 3 Study of RPh201 in NAION, Advances Phase 2 Study in Alzheimer’s Disease in Canada

RPh201 development in US supported by Fast Track Designation by US Food and Drug Administration

August 2, 2018
·
4 min read
Business

Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Second Quarter 2018 Financial Results and Corporate Update

Aldeyra Therapeutics, Inc. will hold a conference call on Thursday, August 9, 2018, at 8:00 a.m. EDT to discuss financial results for the quarter ended June 30, 2018 and provide a corporate update.

August 2, 2018
·
1 min read
Business

CTI BioPharma Reports Second Quarter 2018 Financial Results

Management to Host Conference Call/Webcast Today at 4:30 p.m. Eastern Time

August 2, 2018
·
17 min read
FDA

Sensus Healthcare Receives FDA 510(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as Well as Core System Enhancements

August 2, 2018
·
7 min read
Business

Regenacy Pharmaceuticals Announces Collaboration with the Charcot-Marie-Tooth Association (CMTA) to Advance Ricolinostat for the Treatment of Hereditary Neuropathy

Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced a collaboration with the Charcot-Marie-Tooth Association (CMTA), a registered non-profit organization serving the hereditary neuropathy patient community.

August 2, 2018
·
5 min read
Business

Invicro Names Dr. Brian Avants as Senior Director of Machine Learning

Invicro LLC is a Konica Minolta company and a leading provider of imaging services and software for research and drug development

August 2, 2018
·
4 min read